Published online February 20, 2007
doi:10.1084/jem.20062508
The Journal of Experimental Medicine, Vol. 204, No. 3, 525-532
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Tellam et al.
Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes
Judy Tellam1,
Mark H. Fogg2,
Michael Rist1,
Geoff Connolly1,
David Tscharke1,
Natasha Webb1,
Lea Heslop1,
Fred Wang2, and
Rajiv Khanna1
1 Australian Centre for Vaccine Development and Tumour Immunology Laboratory, Division of Infectious Diseases and Immunology, Clive Berghofer Cancer Research Centre, Queensland Institute of Medical Research, Brisbane (Qld) 4006, Australia
2 Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115
CORRESPONDENCE Rajiv Khanna: rajivK{at}qimr.edu.au OR Judy Tellam: judyT{at}qimr.edu.au
A significant proportion of endogenously processed CD8+ T cell epitopes are derived from newly synthesized proteins and rapidly degrading polypeptides (RDPs). It has been hypothesized that the generation of rapidly degrading polypeptides and CD8+ T cell epitopes from these RDP precursors may be influenced by the efficiency of protein translation. Here we address this hypothesis by using the Epstein-Barr virusencoded nuclear antigen 1 protein (EBNA1), with or without its internal glycine-alanine repeat sequence (EBNA1 and EBNA1
GA, respectively), which display distinct differences in translation efficiency. We demonstrate that RDPs constitute a significant proportion of newly synthesized EBNA1 and EBNA1
GA and that the levels of RDPs produced by each of these proteins directly correlate with the translation efficiency of either EBNA1 or EBNA1
GA. As a consequence, a higher number of major histocompatibility complexpeptide complexes can be detected on the surface of cells expressing EBNA1
GA, and these cells are more efficiently recognized by virus-specific cytotoxic T lymphocytes compared to the full-length EBNA1. More importantly, we also demonstrate that the endogenous processing of these CD8+ T cell epitopes is predominantly determined by the rate at which the RDPs are generated rather than the intracellular turnover of these proteins.
Abbreviations used: DRiP, defective ribosomal product; EBNA1, EBV-encoded nuclear antigen 1 protein; LCL, lymphoblastoid cell line; RDP, rapidly degrading polypeptide.
J. Tellam and M.H. Fogg contributed equally to this work.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Article
-
Translated to death
- Hema Bashyam
J. Exp. Med. 2007 204: 455b.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Tellam, J., Smith, C., Rist, M., Webb, N., Cooper, L., Vuocolo, T., Connolly, G., Tscharke, D. C., Devoy, M. P., Khanna, R.
(2008). From the Cover: Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition. Proc. Natl. Acad. Sci. USA
105: 9319-9324
[Abstract]
[Full Text]
-
Starck, S. R., Cardinaud, S., Shastri, N.
(2008). Immune surveillance obstructed by viral mRNA. Proc. Natl. Acad. Sci. USA
105: 9135-9136
[Full Text]
-
Yoshioka, M., Crum, M. M., Sample, J. T.
(2008). Autorepression of Epstein-Barr Virus Nuclear Antigen 1 Expression by Inhibition of Pre-mRNA Processing. J. Virol.
82: 1679-1687
[Abstract]
[Full Text]
-
Kwun, H. J., da Silva, S. R., Shah, I. M., Blake, N., Moore, P. S., Chang, Y.
(2007). Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mimics Epstein-Barr Virus EBNA1 Immune Evasion through Central Repeat Domain Effects on Protein Processing. J. Virol.
81: 8225-8235
[Abstract]
[Full Text]
-
Tellam, J., Fogg, M. H., Rist, M., Connolly, G., Tscharke, D., Webb, N., Heslop, L., Wang, F., Khanna, R.
(2007). Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes. J. Cell Biol.
176: i11-i11
[Full Text]